Huawei targets heart and diabetes risk detection with new Watch GT 7 series
Huawei has launched the Watch GT 7 series, focusing on advanced health monitoring features such as coronary heart disease and diabetes risk detection. The new wearables also include enhanced sports tracking capabilities and a return to the European market for the Watch 6 series.
Why it matters
Huawei is positioning its wearable technology as a proactive health management tool to compete in the premium smartwatch market.
Munich: Huawei has placed health monitoring at the centre of its latest smartwatch push, unveiling the Huawei Watch GT 7 series with new capabilities aimed at helping users identify potential risks linked to coronary heart disease and diabetes.The company announced the new wearable at its Chase the Wild global product launch in Munich, where it also introduced a broader portfolio spanning tablets, smartphones and audio devices.The Watch GT 7 series represents Huawei’s latest attempt to broaden the role of smartwatches from fitness trackers into devices capable of delivering more detailed health and performance insights. An upgraded Health Insights platform adds Physical Readiness scoring and smart health analysis, designed to turn data collected by the watch into more actionable wellness recommendations. Huawei has also expanded the watch’s sports capabilities, introducing what it describes as industry-first wrist-based turn detection and G-Force detection.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in